Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|January 7, 2006
Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic scoreKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2013
Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosisArmin Finkenstedt, Claudia Auer, Bernhard Glodny, et al.
American Journal of Hematology|May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European studyPatrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Haematologica|April 16, 2017
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopeniaDouglas B Cines, Jeffrey Wasser, Francesco Rodeghiero, et al.
European Journal of Haematology|April 1, 2018
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
Annals of Hematology|September 12, 2014
Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damagePeter Valent, Jörg Berger, Sabine Cerny-Reiterer, et al.
European Journal of Haematology|August 26, 2016
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practiceMichael Steurer, Philippe Quittet, Helen A Papadaki, et al.
Leukemia Research|April 9, 2015
Anagrelide treatment and cardiovascular monitoring in essential thrombocythemia. A prospective observational studyGiovanni Tortorella, Andrea Piccin, Alessia Tieghi, et al.
Blood Transfusion = Trasfusione Del Sangue|August 3, 2016
Platelet gel: a new therapeutic tool with great potentialAndrea Piccin, Angela M Di Pierro, Lucia Canzian, et al.
Blood Advances|May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell LeukemiaJan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.
Pageof 10